Biotechnology Regulation: Views of the Authorities, Investors, and Product Developers in Finland

Autor:	Katrina Nordström, Leena Rahkamo, Outi Nieminen
Rok vydání:	2004
Předmět:	Food and drug administration business.industry Drug Guides Agency (sociology) New product development Public Health Environmental and Occupational Health Economics Pharmacology (medical) Pharmacology (nursing) Product (category theory) Marketing business Biotechnology
Zdroj:	Drug Information Journal. 38:253-264
ISSN:	2164-9200 0092-8615
DOI:	10.1177/009286150403800304
Popis:	This study addresses regulatory issues and problems associated with product development of biotechnological medical products and devices. Data were collected from interviews with Finnish companies, including: (1) recent startup companies and more established companies that develop biopharmaceuticals and devices; (2) primary public and private investors in Finland, including venture and corporate capitalists; (3) private Finnish insurance companies; and (4) representatives of the Finnish national authorities. Two United States biotechnology companies, and European Agency for the Evaluation of Medicinal Products and U.S. Food and Drug Administration representatives were also interviewed.Results show that, in Finland, developers, regulators, and investors have strong confidence in the success of Finnish biotechnology. However, according to this study, the regulatory definition of product categories of new biotechnological products is still evolving. This may lead to difficulties in achieving a definitive und...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0691fb084d4c09510560afee9ecf0101 https://doi.org/10.1177/009286150403800304 Zobrazit plný text záznamu